Biomarker clinical phase outsourcing services refer to the practice of outsourcing the process of biomarker development and clinical trials to external service providers. This involves the use of specialized companies or organizations to conduct various aspects of biomarker research and clinical trials, including data collection, analysis, and interpretation. https://www.globalinsightservices.com/reports/biomarker-clinical-phase-outsourcing-services-market